We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
GLOBETECH PUBLISHING LLC

Download Mobile App




Increased Pressure on Healthcare Providers in the US to Adopt Telehealth

By MedImaging International staff writers
Posted on 23 Aug 2015
Print article
Young digitally-connected patients in the US are pressuring local healthcare providers to adopt telehealth solutions.

To address this, an international IT solutions and managed services provider has identified a three-stage model in the adoption of the telehealth model by healthcare providers.

According to experts at Logicalis Healthcare Solutions, the healthcare-focused arm of Logicalis US, the first stage is an ad-hoc solution; stage two includes a rationalized, departmental telehealth strategy, while stage three is a clinically integrated telehealth solution. Stage three includes advanced data exchange between healthcare providers, patients, laboratories, pharmacies and family caregivers.

Telehealth is already being used regularly in the US by 30 service lines, including radiology, neurology, and stroke care, dermatology, and behavioral health. The service lines fall into four basic telehealth categories. The first category, Synchronous telehealth, includes live, bidirectional, video-based interactions between patients and providers. The second category, Store and Forward, includes transmission of images, clinical results, education, training, and patient portals. The third category, Remote Monitoring, includes the collection of data about vital signs and health progress from chronically ill patients living at home. In the final category, Mobile Health/Wellness, care is supported by mobile devices, and promotes healthy behaviors, sends alerts and reminders, and allows remote case management such as monitoring of vital signs, advice for healthy lifestyles, and other assistance.

Ed Simcox, Healthcare practice leader, Logicalis Healthcare Solutions, said, "In the not-too-distant future, telehealth will be such an integral part of the medical experience that there will be no difference between healthcare and telehealth; telehealth will be healthcare. The tipping point, which Logicalis believes will come within the next four years, will be that point in time when more patients are using telehealth than visiting face to face with their doctors. Today's digital natives expect to interact online with service providers—including their physicians—with the same convenience they experience ride-sharing via Uber or booking a vacation room via Airbnb. To remain relevant, healthcare providers must capitalize on these expectations by providing fully integrated telehealth solutions. Those providers that haven't begun catering to the younger patient demographic using telehealth are already falling behind."

Related Links:

Logicalis Healthcare Solutions


Gold Member
Solid State Kv/Dose Multi-Sensor
AGMS-DM+
New
Ultrasound System
Voluson Signature 18
Thyroid Shield
Standard Thyroid Shield
Computed Tomography (CT) Scanner
Aquilion Serve SP

Print article
Radcal

Channels

MRI

view channel
Image: The emerging role of MRI alongside PSA testing is redefining prostate cancer diagnostics (Photo courtesy of 123RF)

Combining MRI with PSA Testing Improves Clinical Outcomes for Prostate Cancer Patients

Prostate cancer is a leading health concern globally, consistently being one of the most common types of cancer among men and a major cause of cancer-related deaths. In the United States, it is the most... Read more

Nuclear Medicine

view channel
Image: The new SPECT/CT technique demonstrated impressive biomarker identification (Journal of Nuclear Medicine: doi.org/10.2967/jnumed.123.267189)

New SPECT/CT Technique Could Change Imaging Practices and Increase Patient Access

The development of lead-212 (212Pb)-PSMA–based targeted alpha therapy (TAT) is garnering significant interest in treating patients with metastatic castration-resistant prostate cancer. The imaging of 212Pb,... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.